Photo - Exsurgo
play_arrow
View
61618

Exsurgo

New Zealand
Market: Biotech
Stage of the project: Operating business

Date of last change: 06.08.2024
Go to the owner's profile
6
equalizer from 2000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:
 

Idea

Exsurgo is changing the world with its clinically validated, drug free pain solution called Axon.

Axon has just achieved reimbursement in the US and UK.

Current Status

23,000+ treatments delivered. Insurance company reimbursement achieved in US and UK. Commercialisation started.

Problem or Opportunity

Chronic pain affects 1 in 5 people and is an estimated annual US$1.8 trillion problem globally. Chronic pain is frequently treated with Opioids, synthetics and antidepressants with little efficacy, significant side effects and huge personal and societal costs.

Solution (product or service)

As effective as pharmacueticals with none of the side effects Axon is a clinically validated, safe and effectives way to treat chronic pain and mental health issues in the comfort of the patients own home.

Business model

A mixture of hardware and SaaS.

Incubation/Acceleration programs accomplishment

Hub 71
5,00
1
2
3
4
5
1 voice
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility225
star1
Add to favorites
Delete from favorites
share
close
thumb_up0
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Product Video
Presentation